Recent insights into antibiotic resistance in helicobacter pylori eradication

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Wu, Wenming ^a   Yang, Yunsheng ^a   Sun, Gang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL RNA; BISMUTH CITRATE; CLARITHROMYCIN; FURAZOLIDONE; IMIDAZOLE; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASIA; DRUG EFFICACY; ERADICATION THERAPY; GASTROINTESTINAL TRACT; HELICOBACTER; HELICOBACTER INFECTION; HUMAN; MONOTHERAPY; NONHUMAN; PREVALENCE; REVIEW;

EID: 84864957833     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/723183     Document Type: Review

References (75)

1. Necchi V., Candusso M. E., Tava F., Luinetti O., Ventura U., Fiocca R., Ricci V., Solcia E., Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori Gastroenterology 2007 132 3 1009 1023 (Pubitemid 46440875)
2. Friedrich M. J., Microbiome project seeks to understand human body's microscopic residents JAMA 2008 300 7 777 778
3. Bik E. M., Eckburg P. B., Gill S. R., Nelson K. E., Purdom E. A., Francois F., Perez-Perez G., Blaser M. J., Relman D. A., Molecular analysis of the bacterial microbiota in the human stomach Proceedings of the National Academy of Sciences of the United States of America 2006 103 3 732 737 (Pubitemid 43153094)
4. Graham D. Y., Fischbach L., Helicobacter pylori treatment in the era of increasing antibiotic resistance Gut 2010 59 8 1143 1153
5. Scott D., Weeks D., Melchers K., Sachs G., The life and death of Helicobacter pylori Gut 1998 43 supplement 1 S56 S60
6. Vakil N., Megraud F., Eradication therapy for Helicobacter pylori Gastroenterology 2007 133 3 985 1001 (Pubitemid 47374146)
7. Bloom S. R., Polak J. M., Physiology of gastrointestinal hormones Biochemical Society Transactions 1980 8 1 15 17 (Pubitemid 10095368)
8. Moayyedi P., Sahay P., Tompkins D. S., Axon A. T. R., Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori European Journal of Gastroenterology and Hepatology 1995 7 9 835 840
9. Midolo P. D., Turnidge J. D., Munkhof W. J., Berry V., Woodnutt G., Is bactericidal activity of amoxicillin against Helicobacter pylori concentration dependent? Antimicrobial Agents and Chemotherapy 1996 40 5 1327 1328 (Pubitemid 26136062)
10. Atherton J. C., Cockayne A., Balsitis M., Kirk G. E., Hawkey C. J., Spiller R. C., Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine Gut 1995 36 5 670 674
11. Kalebi A., Rana F., Mwanda W., Lule G., Hale M., Histopathological profile of gastritis in adult patients seen at a referral hospital in Kenya World Journal of Gastroenterology 2007 13 30 4117 4121 (Pubitemid 47323168)
12. Graham D. Y., Lu H., Yamaoka Y., African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths Journal of Digestive Diseases 2009 10 2 77 84
13. Gao W., Cheng H., Hu F., Li J., Wang L., Yang G., Xu L., Zheng X., The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China Helicobacter 2010 15 5 460 466
14. Horiki N., Omata F., Uemura M., Suzuki S., Ishii N., Iizuka Y., Fukuda K., Fujita Y., Katsurahara M., Ito T., Cesar G. E., Imoto I., Takei Y., Annual change of primary resistance to clarithromycin among Helicobacter pylori isolates from 1996 through 2008 in Japan Helicobacter 2009 14 5 86 90
15. Marie M. A. M., Patterns of Helicobacter pylori resistance to metronidazole, clarithormycin and amoxicillin in Saudi Arabia Journal of Bacteriology and Virology 2008 38 4 173 178
16. Agudo S., Pérez-Pérez G., Alarcn T., Lpez-Brea M., High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain Journal of Clinical Microbiology 2010 48 10 3703 3707
17. Janssen M. J. R., Hendrikse L., de Boer S. Y., Bosboom R., de Boer W. A., Laheij R. J. F., Jansen J. B. M. J., Helicobacter pylori antibiotic resistance in a Dutch region: trends over time The Netherlands Journal of Medicine 2006 64 6 191 195 (Pubitemid 43970920)
18. Storskrubb T., Aro P., Ronkainen J., Wreiber K., Nyhlin H., Bolling-Sternevald E., Talley N. J., Engstrand L., Agréus L., Antimicrobial susceptibility of Helicobacter pylori strains in a random adult Swedish population Helicobacter 2006 11 4 224 230 (Pubitemid 44051347)
19. Fischbach L. A., Goodman K. J., Feldman M., Aragaki C., Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis International Journal of Epidemiology 2002 31 1 128 139 (Pubitemid 34284915)
20. Osato M. S., Reddy R., Reddy S. G., Penland R. L., Malaty H. M., Graham D. Y., Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States Archives of Internal Medicine 2001 161 9 1217 1220 (Pubitemid 32691518)
21. Mendona S., Ecclissato C., Sartori M. S., Godoy A. P. O., Guerzoni R. A., Degger M., Pedrazzoli J., Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil Helicobacter 2000 5 2 79 83 (Pubitemid 34951164)
22. De Francesco V., Giorgio F., Hassan C., Manes G., Vannella L., Panella C., Ierardi E., Zullo A., Worldwide H. pylori antibiotic resistance: a systematic review Journal of Gastrointestinal and Liver Diseases 2010 19 4 409 414
23. Mégraud F., H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 2004 53 9 1374 1384 (Pubitemid 39120130)
24. Perez Aldana L., Kato M., Nakagawa S., Kawarasaki M., Nagasako T., Mizushima T., Oda H., Kodaira J., Shimizu Y., Komatsu Y., Zheng R., Takeda H., Sugiyama T., Asaka M., Mototsugu K., The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance Helicobacter 2002 7 5 306 309 (Pubitemid 35221674)
25. Yamaoka Y., Orito E., Mizokami M., Gutierrez O., Saitou N., Kodama T., Osato M. S., Kim J. G., Ramirez F. C., Mahachai V., Graham D. Y., Helicobacter pylori in North and South America before Columbus FEBS Letters 2002 517 13 180 184 (Pubitemid 34327655)
26. Yamaoka Y., Mechanisms of disease: Helicobacter pylori virulence factors Nature Reviews Gastroenterology and Hepatology 2010 7 11 629 641
27. Yamaoka Y., Kato M., Asaka M., Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains Internal Medicine 2008 47 12 1077 1083
28. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E. J., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 2007 56 6 772 781 (Pubitemid 46854190)
29. Basu P. P., Rayapudi K., Pacana T., Shah N. J., Krishnaswamy N., Flynn M., A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori The American Journal of Gastroenterology 2011 106 11 1970 1975
30. Hsu P. I., Wu D. C., Chen A., Peng N. J., Tseng H. H., Tsay F. W., Lo G. H., Lu C. Y., Yu F. J., Lai K. H., Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures European Journal of Clinical Investigation 2008 38 6 404 409 (Pubitemid 351712923)
31. Chuah S.-K., Tsay F.-W., Hsu P.-I., Wu D.-C., A new look at anti- Helicobacter pylori therapy World Journal of Gastroenterology 2011 17 35 3971 3975
32. Gisbert J. P., Calvet X., O'Connor A., Mégraud F., O'Morain C. A., Sequential therapy for Helicobacter pylori eradication: a critical review Journal of Clinical Gastroenterology 2010 44 5 313 325
33. Wu D. C., Hsu P. I., Wu J. Y., Opekun A. R., Kuo C. H., Wu I. C., Wang S. S. W., Chen A., Hung W. C., Graham D. Y., Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection Clinical Gastroenterology and Hepatology 2010 8 1 36 41.e1
34. Malfertheiner P., Megraud F., O'Morain C. A., Atherton J., Axon A. T. R., Bazzoli F., Gensini G. F., Gisbert J. P., Graham D. Y., Rokkas T., El-Omar E. M., Kuipers E. J., Management of Helicobacter pylori infectionthe Maastricht IV/ Florence consensus report Gut 2012 61 5 646 664
35. O'Morain C., Borody T., Farley A., De Boer W. A., Dallaire C., Schuman R., Piotrowski J., Fallone C. A., Tytgat G., Mégraud F., Spénard J., Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study Alimentary Pharmacology and Therapeutics 2003 17 3 415 420 (Pubitemid 36259404)
36. Laine L., Hunt R., EI-Zimaity H., Nguyen B., Osato M., Spénard J., Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial American Journal of Gastroenterology 2003 98 3 562 567 (Pubitemid 36348526)
37. Phillips R. H., Whitehead M. W., Doig L. A., Sieniawska C. E., Trevor Delves H., Thompson R. P. H., Powell J. J., Is eradication of Helicobacter pylori with colloidal Bismuth subcitrate quadruple therapy safe? Helicobacter 2001 6 2 151 156 (Pubitemid 32601675)
38. Chey W. D., Wong B. C. Y., American College of Gastroenterology guideline on the management of Helicobacter pylori infection The American Journal of Gastroenterology 2007 102 8 1808 1825 (Pubitemid 47206706)
39. Nishizawa T., Suzuki H., Hibi T., Quinolone-based third-line therapy for Helicobacter pylori eradication Journal of Clinical Biochemistry and Nutrition 2009 44 2 119 124
40. Van Der Poorten D., Katelaris P. H., The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice Alimentary Pharmacology and Therapeutics 2007 26 11-12 1537 1542 (Pubitemid 350178803)
41. Mégraud F., Lehours P., Helicobacter pylori detection and antimicrobial susceptibility testing Clinical Microbiology Reviews 2007 20 2 280 322 (Pubitemid 46709306)
42. Vaira D., Zullo A., Vakil N., Gatta L., Ricci C., Perna F., Hassan C., Bernabucci V., Tampieri A., Morini S., Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial Annals of Internal Medicine 2007 146 8 556 563 (Pubitemid 351650536)
43. Hsu P. I., Wu D. C., Wu J. Y., Graham D. Y., Modified Sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days Helicobacter 2011 16 2 139 145
44. Malfertheiner P., Bazzoli F., Delchier J. C., Celiski K., Gigure M., Rivire M., Mégraud F., Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial The Lancet 2011 377 9769 905 913
45. Liou J. M., Lin J. T., Chang C. Y., Chen M. J., Cheng T. Y., Lee Y. C., Chen C. C., Sheng W. H., Wang H. P., Wu M. S., Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design Gut 2010 59 5 572 578
46. Toracchio S., Capodicasa S., Soraja D. B., Cellini L., Marzio L., Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin Digestive and Liver Disease 2005 37 1 33 38 (Pubitemid 41070562)
47. Rimbara E., Fischbach L. A., Graham D. Y., Optimal therapy for Helicobacter pylori infections Nature Reviews Gastroenterology and Hepatology 2011 8 2 79 88
48. Falush D., Kraft C., Taylor N. S., Correa P., Fox J. G., Achtman M., Suerbaum S., Recombination and mutation during long-term gastric colonization by Helicobacter pylori: estimates of clock rates, recombination size, and minimal age Proceedings of the National Academy of Sciences of the United States of America 2001 98 26 15056 15061 (Pubitemid 34013968)
49. Torres-Debat M. E., Pérez-Pérez G., Olivares A., Fernndez L., Raisler K., Gonzalez N., Stein S., Bazet M. C., Alalln W., Cohen H., Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay Revista Espanola de Enfermedades Digestivas 2009 101 11 757 762
50. Vilaichone R. K., Mahachai V., Graham D. Y., Helicobacter pylori Diagnosis and Management Gastroenterology Clinics of North America 2006 35 2 229 247 (Pubitemid 44118666)
51. Chen S., Li Y., Yu C., Oligonucleotide microarray: a new rapid method for screening the 23S rRNA gene of Helicobacter pylori for single nucleotide polymorphisms associated with clarithromycin resistance Journal of Gastroenterology and Hepatology 2008 23 1 126 131 (Pubitemid 350265195)
52. Hirata K., Suzuki H., Nishizawa T., Tsugawa H., Muraoka H., Saito Y., Matsuzaki J., Hibi T., Contribution of efflux pumps to clarithromycin resistance in Helicobacter pylori Journal of Gastroenterology and Hepatology 2010 25 supplement 1 S75 S79
53. Webber M. A., Piddock L. J. V., The importance of efflux pumps in bacterial antibiotic resistance Journal of Antimicrobial Chemotherapy 2003 51 1 9 11 (Pubitemid 36163821)
54. DeLoney C. R., Schiller N. L., Characterization of an in vitro-selected amoxicillin-resistant strain of Helicobacter pylori Antimicrobial Agents and Chemotherapy 2000 44 12 3368 3373 (Pubitemid 33009497)
55. Gerrits M. M., Godoy A. P. O., Kuipers E. J., Ribeiro M. L., Stoof J., Mendona S., Van Vliet A. H. M., Pedrazzoli J., Kusters J. G., Multiple mutations in or adjacent to the conserved penicillin-binding protein motifs of the penicillin-binding protein 1A confer amoxicillin resistance to Helicobacter pylori Helicobacter 2006 11 3 181 187 (Pubitemid 43736553)
56. Qureshi N. N., Morikis D., Schiller N. L., Contribution of specific amino acid changes in penicillin binding protein 1 to amoxicillin resistance in clinical Helicobacter pylori isolates Antimicrobial Agents and Chemotherapy 2011 55 1 101 109
57. Tsugawa H., Suzuki H., Satoh K., Hirata K., Matsuzaki J., Saito Y., Suematsu M., Hibi T., Two amino acids mutation of ferric uptake regulator determines Helicobacter pylori resistance to metronidazole Antioxidants and Redox Signaling 2011 14 1 15 23
58. Moore J. M., Salama N. R., Mutational analysis of metronidazole resistance in Helicobacter pylori Antimicrobial Agents and Chemotherapy 2005 49 3 1236 1237 (Pubitemid 40327759)
59. Matteo M. J., Pérez C. V., Domingo M. R., Olmos M., Sanchez C., Catalano M., DNA sequence analysis of rdxA and frxA from paired metronidazole-sensitive and -resistant Helicobacter pylori isolates obtained from patients with heteroresistance International Journal of Antimicrobial Agents 2006 27 2 152 158 (Pubitemid 43138848)
60. Bereswill S., Krainick C., Sthler F., Herrmann L., Kist M., Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori FEMS Immunology and Medical Microbiology 2003 36 3 193 198 (Pubitemid 36556039)
61. Choi S. S., Chivers P. T., Berg D. E., Point mutations in Helicobacter pylori's fur regulatory gene that alter resistance to metronidazole, a prodrug activated by chemical reduction PLoS ONE 2011 6 3
62. Tankovic J., Lascols C., Sculo Q., Petit J. C., Soussy C. J., Single and double mutations in gyra but not in gyrb are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori Antimicrobial Agents and Chemotherapy 2003 47 12 3942 3944 (Pubitemid 37485011)
63. Chung J.-W., Lee G. H., Jeong J.-Y., Lee S. M., Jung J. H., Choi K. D., Song H. J., Jung H.-Y., Kim J.-H., Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance Journal of Gastroenterology and Hepatology 2012 27 3 493 497
64. Miyachi H., Miki I., Aoyama N., Shirasaka D., Matsumoto Y., Toyoda M., Mitani T., Morita Y., Tamura T., Kinoshita S., Okano Y., Kumagai S., Kasuga M., Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan Helicobacter 2006 11 4 243 249 (Pubitemid 44051350)
65. Akada J. K., Shirai M., Fujii K., Okita K., Nakazawa T., In vitro anti-Helicobacter priori activities of new rifamycin derivatives, KRM-1648 and KRM-1657 Antimicrobial Agents and Chemotherapy 1999 43 5 1072 1076 (Pubitemid 29214727)
66. Heep M., Beck D., Bayerdrffer E., Lehn N., Rifampin and rifabutin resistance mechanism in Helicobacter pylori Antimicrobial Agents and Chemotherapy 1999 43 6 1497 1499 (Pubitemid 29259353)
67. Suzuki S., Suzuki H., Nishizawa T., Kaneko F., Ootani S., Muraoka H., Saito Y., Kobayashi I., Hibi T., Past rifampicin dosing determines rifabutin resistance of Helicobacter pylori Digestion 2009 79 1 1 4
68. Glocker E., Bogdan C., Kist M., Characterization of rifampicin-resistant clinical Helicobacter pylori isolates from Germany Journal of Antimicrobial Chemotherapy 2007 59 5 874 879 (Pubitemid 47073357)
69. Chopra I., Roberts M., Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance Microbiology and Molecular Biology Reviews 2001 65 2 232 260 (Pubitemid 32538179)
70. Ribeiro M. L., Gerrits M. M., Benvengo Y. H. B., Berning M., Godoy A. P. O., Kuipers E. J., Mendona S., Van Vliet A. H. M., Pedrazzoli J., Kusters J. G., Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP FEMS Immunology and Medical Microbiology 2004 40 1 57 61 (Pubitemid 38087966)
71. Toledo H., Lpez-Sols R., Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori Journal of Antimicrobial Chemotherapy 2009 65 3 470 473
72. Gerrits M. M., De Zoete M. R., Arents N. L. A., Kuipers E. J., Kusters J. G., 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori Antimicrobial Agents and Chemotherapy 2002 46 9 2996 3000
73. Anoushiravani M., Falsafi T., Niknam V., Proton motive force-dependent efflux of tetracycline in clinical isolates of Helicobacter pylori Journal of Medical Microbiology 2009 58 10 1309 1313
74. Dorer M. S., Talarico S., Salama N. R., Helicobacter pylori's unconventional role in health and disease PLoS Pathogens 2009 5 10
75. Suzuki R., Shiota S., Yamaoka Y., Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori Infection, Genetics and Evolution 2012 12 2 203 213